Financhill
Back

Perspective Therapeutics Quote, Financials, Valuation and Earnings

Perspective Therapeutics Price Quote

$3.49
+0.02 (+16.33%)
(Updated: November 23, 2024 at 5:28 AM ET)

Perspective Therapeutics Key Stats

Sell
30
Perspective Therapeutics (CATX) is a Sell

Day range:
$2.94 - $3.59
52-week range:
$2.28 - $19.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.74
P/B ratio:
0.71%

Volume:
9.2M
Avg. volume:
1.5M
1-year change:
36.08%
Market cap:
$234.5M
Revenue:
$0
EPS:
$-1.46

How Much Does Perspective Therapeutics Make?

Data Unavailable

Is Perspective Therapeutics Growing As A Company?

Data Unavailable

Perspective Therapeutics Stock Price Performance

What Is Perspective Therapeutics 52-Week High & Low?

Perspective Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Perspective Therapeutics?

Is Perspective Therapeutics Cash Flow Positive?

  • What Is CATX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$696K
  • What Is Perspective Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $289.4M
  • What Is Perspective Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$80.4M

Perspective Therapeutics Return On Invested Capital

Data Unavailable

Perspective Therapeutics Earnings Date & Stock Price

Perspective Therapeutics Competitors

Perspective Therapeutics Dividend Yield

Perspective Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.06%
Revenue: 0% 55.1%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.17
Upside from Last Price: 481.17%

Major Shareholders

  • How many CATX shares are owned by institutional investors?
    63.7M CATX shares are owned by institutional investors
  • How many CATX shares are owned by insiders?
    4.3M CATX shares are owned by insiders